+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06772675

Implementing Vancomycin Reduction Practices with and without External Facilitation in Neonatal Intensive Care Units

Led by Children's Hospital of Philadelphia · Updated on 2026-09-24

13

Participants Needed

13

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research evaluates ways to improve the use of vancomycin reduction practices VRP in neonatal intensive care units NICUs. The study is designed as a multi-center, cluster randomized trial involving hospital sites affiliated with major healthcare networks. It aims to assess how external support impacts the implementation of key VRP components to reduce unnecessary antibiotic use in newborns. The study compares two groups of NICU sites those receiving monthly guidance from an external facilitator who works with local champions using a detailed support guide, and those not receiving this external facilitation. Both groups will have access to interventions aimed at staff education, identification of local champions, unit audits, feedback, and a clinical decision support tool to encourage adherence to VRP. Participants are hospital sites rather than individual patients, with the study lasting approximately 2.5 years from the start of implementation to the end of sustainment. Researchers will monitor how well sites follow VRP practices and assess the appropriateness and acceptance of these methods. The study focuses on center-level fidelity and does not involve direct patient treatments or procedures.

CONDITIONS

Brief Title

Vancomycin Reduction Practices (VRP) in the NICU

Research Team

K

Kayla Gilpin

M

Morgan Gabbert

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here